CytomX Therapeutics, Inc. (CTMX) › Shares OutstandingCytomX Therapeutics, Inc. (CTMX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 996.5K2015: 36.03M2016: 36.49M2017: 38.48M2018: 45.08M2019: 45.52M2020: 48.25M2021: 65.39M2022: 66.23M2023: 67.31M2024: 80.10M2025: 170.19M170.19M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025170.19M+112.5%202480.10M+19.0%202367.31M+1.6%202266.23M+1.3%202165.39M+35.5%202048.25M+6.0%201945.52M+1.0%201845.08M+17.2%201738.48M+5.4%201636.49M+1.3%201536.03M+3515.9%2014996.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share